ICPT(Delisted)
Intercept Pharmaceuticals·NASDAQ
--
--(--)
ICPT fundamentals
Intercept Pharmaceuticals (ICPT) released its earnings on Nov 1, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Nov 1, 2017
EPS
Revenue
Revenue & Expenses
ICPT has released its 2023 Q3 earnings report, with revenue of 88.79M, reflecting a YoY change of 14.44%, and net profit of -2.79M, showing a YoY change of -101.04%. The Sankey diagram below clearly presents ICPT's revenue sources and cost distribution.
Key Indicators
Intercept Pharmaceuticals (ICPT) key financial stats and ratios, covering profitability, financial health, and leverage.
Intercept Pharmaceuticals (ICPT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Intercept Pharmaceuticals (ICPT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Intercept Pharmaceuticals (ICPT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Intercept Pharmaceuticals (ICPT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Intercept Pharmaceuticals (ICPT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
